The Cultivated B (TCB) began discussions with the European Food Safety Authority (EFSA) and officially entered the pre-submission process for novel food approval of a novel or non-farmed sausage product. Subsequent to the official submission, TCB will emerge as world’s first biotech company to apply for Ecertification for cultivated meat. This is a pivotal first step in the evolution of the cultivated meat market and establishes a viable path towards large-scale commercial production.
“EFSA’s Novel Food regulatory approvals process is among the most robust in the world, including a thorough and evidence-based assessment of food safety and nutritional value. For cultivated meat to become available in Europe, where this food was born, would mark a paradigm shift for the sector,” said Seth Roberts, policy manager at the Good Food Institute Europe.
One of the most significant challenges in the cultivated meat sector is achieving production at the enormvolumes required by the food producer industry. In addition, food safety concerns and regulatory compliance further hinder cultivated meat from reaching consumers. TCB’s early engagement with Eis a testament to knocking down these barriers, propelling the industry to democratize cultivated meat for the masses without compromising on quality or sustainability.
“This is more than just a certification process; it’s a testament to our advanced, industrial-scale cellular agriculture technology and also a reflection of our unwavering commitment to usher in a new era of food production-one where health, taste, ethics and sustainability converge seamlessly,” said TCB CEO Dr. Hamid Noori.“The European cultivated meat sector has vast potential and considerable opportunity for growth. As this market gains prominence, our objective is to ensure consistent access to high-quality, sustainable meat for everyone. Attaining Ecertification is a significant step in this direction.”
** Click here to read the full-text **
